Flow diverters market seen reaching $950 million by 2030

The Business Research Company says the global flow diverters market will grow from $550 million in 2025 to $620 million in 2026, then reach $950 million by 2030. The report points to rising aneurysm diagnoses, broader use of minimally invasive neurovascular treatments and faster adoption in North America and Asia-Pacific.

Why it matters: - Flow diverters are becoming a bigger part of intracranial aneurysm treatment as hospitals and clinics look for less invasive options than clipping or coiling. - The market's growth signals stronger demand for devices that can reduce rupture risk while preserving blood flow in nearby vessels. - The report says the market is expected to expand at an 11.7% CAGR in 2026 and an 11.4% CAGR through 2030.

What happened: - The Business Research Company released a flow diverters market report on Aug. 7, 2026. - The report projects market value will rise from $0.55 billion in 2025 to $0.62 billion in 2026. - The market is forecast to reach $0.95 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - Download a free sample of the report. - View the full market report.

The details: - Flow diverters are mesh-like stents used endovascularly to treat large or complex intracranial aneurysms. - The devices are placed in the parent blood vessel to redirect blood flow away from the aneurysm sac. - That diversion supports clot formation inside the aneurysm and lowers rupture risk. - The report says historical growth came from limited specialized flow diverter options, ongoing reliance on clipping and coiling, greater awareness of intracranial aneurysm treatment, stronger neurovascular capabilities in hospitals and clinics, and early nitinol stent adoption. - The report says future growth will be driven by next-generation devices with better flexibility, rising demand for minimally invasive neurovascular procedures, more hospital endovascular investment, more regulatory clearances and imaging and AI-assisted deployment tools. - Reported trends include broader use for complex aneurysms, more advanced nitinol and cobalt-chromium devices, more endovascular treatment centers and a stronger focus on reducing complications and improving patient safety. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics, future trend analysis and updated graphics and tables.

Between the lines: - The market is shifting from a niche neurovascular category toward wider clinical use as device design improves and treatment access expands. - The emphasis on imaging and AI-assisted deployment suggests competition may increasingly hinge on precision, not just device availability. - Rising aneurysm detection rates strengthen the case for growth because diagnosis often drives treatment demand. - PubMed reported in November 2025 that about 3% of adults have an unruptured intracranial aneurysm, with rates as high as 10% in high-risk groups.

What's next: - The report expects continued adoption of minimally invasive aneurysm treatment as device performance improves and hospitals expand endovascular infrastructure. - Asia-Pacific's growth trajectory suggests more commercial attention on emerging healthcare markets. - More regulatory clearances could accelerate launches of newer flow diverter devices. - Greater use of advanced materials and deployment technologies may shape the next wave of product differentiation.

The bottom line: - Flow diverters are moving from specialist tools to a broader growth market, with rising aneurysm detection and device innovation driving the next phase of expansion.